DRX Revolution Mobile X-Ray System, Model DRXR-1, Verona Street Rochester, NY 14608 Catalog Nu...
FDA Device Recall #Z-0090-2014 — Class II — July 26, 2013
Recall Summary
| Recall Number | Z-0090-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 26, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Carestream Health, Inc. |
| Location | Rochester, NY |
| Product Type | Devices |
| Quantity | 23 units installed total (11 domestically & 12 internationally) |
Product Description
DRX Revolution Mobile X-Ray System, Model DRXR-1, Verona Street Rochester, NY 14608 Catalog Numbers 1019397, 1023415, 1023423 --- Made in USA by Carestream Health, Inc. 150 The device is designed to perform radiographic x-ray examinations on all pediatric and adult patients, in all patient treatment areas.
Reason for Recall
During an audit, Carestream discovered a DRX-1 System that captured an image which displayed an artifact. This issue was discovered in manufacturing. It occurs when the DRX product console software is updated to v5.6b software and the detector is not calibrated before use.
Distribution Pattern
Worldwide Distribution - US (nationwide) including the states of New York, Massachusetts, Pennsylvania, Illinois, Texas, California and Louisiana., and the countries of Australia, Canada, Finland, Italy, Switzerland and United Kingdom.
Lot / Code Information
Serial numbers: U.S. - 134,152,173,174,200,205,222,312,349,353,412, Worldwide Serial numbers: 469, 445, 306, 410, 453, 204, 483, 300, 171, 218
Other Recalls from Carestream Health, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0437-2024 | Class II | DRX Revolution Mobile X-Ray System | Oct 2, 2023 |
| Z-0289-2024 | Class II | The DRX-Revolution Mobile X-Ray System is a dia... | Oct 2, 2023 |
| Z-1206-2023 | Class II | DRX-Compass/DR-FIT X-ray Systems with Firmware ... | Jan 30, 2023 |
| Z-0806-2020 | Class II | Kodak DirectView DR3000/3500 - Product Usage: p... | Jan 6, 2020 |
| Z-1207-2019 | Class II | OnSight 3D Extremity System- X-Ray, Tomography ... | Mar 19, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.